Unbound ligand drives hepatocyte taurocholate and BSP uptake at physiological albumin concentration. 1994

D Sorrentino, and A Zifroni, and K van Ness, and P D Berk
Department of Medicine (Division of Liver Diseases), Mount Sinai School of Medicine, New York, New York 10029.

We have recently shown (D. Sorrentino, R.B. Robinson, C.-L. Kiang, and P.D. Berk. J. Clin. Invest. 84: 1325-1333, 1989) that, in a variety of isolated cell types, the uptake of oleate at physiological albumin concentrations is consistent with traditional pharmacokinetic theory (i.e., driven by unbound ligand). Lower albumin concentrations were associated with a deviant uptake pattern for which alternative theories have been proposed. Whether other classes of organic anions exhibit similar behavior is unknown. Therefore, we examined the effect of albumin on uptake of two widely studied organic anions, sulfobromophthalein (BSP) and taurocholate. Initial uptake velocity of [35S]BSP and [3H]taurocholate by isolated hepatocytes was studied employing a fixed albumin concentration and ligand-to-albumin molar ratios from 0.01:1 to 2:1 for taurocholate and 0.031:1 to 0.75:1 for BSP. In other experiments, albumin and ligand were altered in parallel, keeping their molar ratio constant. Unbound taurocholate concentrations were measured directly by equilibrium dialysis; unbound BSP concentrations were calculated from published data (K.J. Baker and S.E. Bradley. J. Clin. Invest. 45: 281-287, 1966). At 600 microM albumin, uptake of both ligands was a function of the unbound ligand concentration. At low ligand-to-albumin molar ratios and consequent unbound ligand concentrations this relationship was linear; over the entire range of unbound ligand concentrations studied, both ligands exhibited Michaelis-Menten kinetics, with definable maximal velocity and Michaelis constant values. At low albumin concentrations, the relationships between uptake and unbound ligand were unchanged for taurocholate; however, BSP exhibited altered kinetics similar to those observed with oleate. Nontraditional uptake kinetics at low albumin concentrations appear to correlate with very high affinity for albumin.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012709 Serum Albumin A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules. Plasma Albumin,Albumin, Serum
D013448 Sulfobromophthalein A phenolphthalein that is used as a diagnostic aid in hepatic function determination. Bromsulphalein,Bromosulfophthalein,Bromosulphthalein,Bromthalein,Sulfobromophthalein Disodium,Sulfobromophthalein Sodium,Tetrabromsulphthalein,Disodium, Sulfobromophthalein,Sodium, Sulfobromophthalein
D013656 Taurocholic Acid The product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and cholerectic. Cholyltaurine,Taurine Cholate,Taurocholate,Sodium Taurocholate,Taurocholate Sodium,Taurocholic Acid, (5 alpha)-Isomer,Taurocholic Acid, (7 beta)-Isomer,Taurocholic Acid, Monolithium Salt,Taurocholic Acid, Monosodium Salt,Taurocholate, Sodium
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

D Sorrentino, and A Zifroni, and K van Ness, and P D Berk
August 1988, Journal of pharmacokinetics and biopharmaceutics,
D Sorrentino, and A Zifroni, and K van Ness, and P D Berk
December 1994, The American journal of physiology,
D Sorrentino, and A Zifroni, and K van Ness, and P D Berk
April 1987, The American journal of physiology,
D Sorrentino, and A Zifroni, and K van Ness, and P D Berk
February 2012, Pediatrics international : official journal of the Japan Pediatric Society,
D Sorrentino, and A Zifroni, and K van Ness, and P D Berk
January 1987, Clinical science (London, England : 1979),
D Sorrentino, and A Zifroni, and K van Ness, and P D Berk
March 1981, The Journal of pharmacology and experimental therapeutics,
D Sorrentino, and A Zifroni, and K van Ness, and P D Berk
July 2019, Pharmacotherapy,
D Sorrentino, and A Zifroni, and K van Ness, and P D Berk
May 2024, Nature,
D Sorrentino, and A Zifroni, and K van Ness, and P D Berk
September 1994, The American journal of physiology,
D Sorrentino, and A Zifroni, and K van Ness, and P D Berk
January 1974, Naunyn-Schmiedeberg's archives of pharmacology,
Copied contents to your clipboard!